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Crude dichloromethane and 90%methanolic extracts of plants used traditionally in the treatment of wounds and retained placenta were screened for
their antibacterial, anti-inflammatory (cyclooxygenase-1 and-2) activities and investigated for potential mutagenic effects. Antibacterial activity was
evaluated using the micro-dilution assay. The bacterial strains used were Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 25922) and
Pseudomonas aeruginosa (ATCC 27853). DCM extracts of Dicerocaryum eriocarpum, Pterocarpus angolensis, Ricinus communis and Schkuhria
pinnata exhibited the highest antibacterial activity. In the anti-inflammatory assay, dichloromethane extracts of stems ofCissus quadrangularis and roots
of Jatropha zeyheri showed selective inhibition of COX-2 (75% and 77%), while dichloromethane extracts of the shoots of S. pinnata showed selective
inhibition of COX-1. None of the plant extracts were mutagenic in the Salmonella typhimurium Ames test (strain TA98). The results suggest that most
plants used traditionally for treating wounds and retained placenta in animals are effective in combating infection and reduction of pain. Lack of
mutagenicity suggests that these plants are probably safe for use.
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Ethnoveterinary medicine (EVM) is widely practiced by
South African small scale farmers (Masika et al., 2000; Van der
Merwe et al., 2001). People have used these remedies for
generations and many reasons have been advanced as to why
the practice continues. Farmers claim that medicinal plants are
more efficacious than pharmaceuticals for chronic pathologies.
They are reputed to have no side effects and no withdrawal
periods for consumption of meat from treated animals are
needed since the plants are thought to be non-toxic. In general,
ethnoveterinary products are used after conventional pharma-
ceutical medicines, for chronic cases, proved ineffective.⁎ Corresponding author.
E-mail address: rcpgd@ukzn.ac.za (J. Van Staden).
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doi:10.1016/j.sajb.2007.03.003Aligning indigenous names of diseases used by traditional
farmers to modern veterinary practice is recognized as a difficult
task (McCorkle and Mundy, 1992). Wounds are defined by
farmers to include sores, warts and lumpy skin disease. Tsonga
speaking people of South Africa invariably use the same name
of ‘matsuna’ for wounds and lumpy skin disorders (Luseba and
Van der Merwe, 2006). The Setswana term for sores and
wounds (dintho) has a broad definition and includes inflamed
skin lesions, abscesses and lesions of internal organs such as the
lungs and liver (Van der Merwe et al., 2001). Farmers recognize
tick bites as the biggest causes of wounds but thorns and other
hard plant materials found in the Bushveld can contribute.
Farmers mostly use a range of plants (Table 1) as EVM
remedies (Luseba and Van der Merwe, 2006). It is interesting that
bitter (Aloe marlothii) and irritant (Sarcostemma viminale) plants
are generally used in treatment of wounds. Van der Merwe et al.
(2001) have also attributed the use of medicinal plants to thets reserved.
Table 1
Plants and parts administrated for treatment of wounds and retained placenta in animals in South Africa
Family and botanical name Common names Indication Plant part used Application
Araliaceae Cussonia spicata
Thunb. Dvd Merwe 63
Musenje: Tsonga;
Musenzhe: Venda
Retained placenta Bark The bark is crushed and mixed with water
Asclepiadaceae Sarcostemma
viminale R. (Br.) Dluseba
11/12/02
Neta: Tsonga; Mutungu:
Venda
Wound Aerial part Crushed and applied directly on the wound.
Very effective against maggots
Asphodelaceae Aloe marlothii
Berger subsp. marlothii
Kaalplaas 032
Mhangani: Tsonga;
Tshikopa: Venda;
Mokgopa: Setswana
NCD Leaves Leaves are crushed and the juice is
applied on sores
Asteraceae Schkuhria pinnata
(Lam.) Dvd Merwe 61
Santhloko lefero:
Setswana;
Eye infections
Pneumonia, diarrhoea
Heartwater
Aerial parts The shoots are crushed and mixed with
water for dosing the animal for systemic
ailments or applied directly on the eye
Euphorbiaceae Jatropha zeyheri
Sond. Dluseba 10/11/02
Xidomeja/Mudomeja:
Tsonga; mafuredonga:
Venda
General ailments;
Wounds
Roots Together with P. angolensis, the most
used plant. Fresh or dry roots are ground,
soaked in water and dosed to animals
Euphorbiaceae Ricinus communis
Linn. Dvd Merwe 29/01/02
Mokhura: Setswana Wounds and sores Leaves Leaves are made into poultices and are
widely applied to wounds, sores and boils
Fabaceae Pterocarpus angolensis
DC. Dluseba 10/12/02
Vhangazi/Murhotso:
Tsonga
General illness,
thriftiness,
Bark The bark is chopped, soaked in cold water,
dosed once only with bottle or horn (approximately
750 ml) after the water has changed to a
reddish colour or it is boiled for 30 to 60 min
Pedaliaceae Dicerocaryum
eriocarpum (Decne.) Abels
Dvd Merwe 101
Dinda/Dindza:
Tsonga;
Dystocia, Retained
placenta
Shoots The shoots are crushed and mixed with
water. It is applied topically as a lubricant
during difficult calving and given orally
(5 l) for retained placenta
Rhamnaceae Ziziphus mucronata
Willd. subsp. Mucronata
Dvd Merwe 100
Mutshetshete: Venda;
Mokgalo: Setswana
Wounds and sores Roots Decoctions of roots are applied externally to boils,
sores and glandular swelling
Vitaceae Cissus quandrangularis
(Linn) Dluseba 10/12/02
Nyangala: Tsonga Wounds; lactophore Shoots The shoots are crushed and applied
directly on wounds
Source: (Van der Merwe et al., 2001; Luseba and Van der Merwe, 2006).
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angolensis probably for its red colour, and Dicerocaryum
eriocarpum which is soapy for a retained placenta.
Most EVM studies so far focused on capturing traditional
knowledge and evaluating EVM remedies by empiric methods
such as the veterinary consistency as stipulated by Kansonia and
Ansay (1997) which relies on anecdotes provided by farmers.
Otherwise, the scientific rationale behind the use of these
remedies has been deducted in some cases from research in
human traditional medicine. There is need for specific studies
on animal pathologies and diseases. This study is a first attempt
to evaluate the biological activities of the ten most used plants in
North-West and Limpopo Provinces of South Africa as EVM
remedies in treatment of wounds and retained placenta.
2. Materials and methods
2.1. Data collection
Rapid rural appraisal methods were used to collect the
information on plants used in the treatment of wounds and
retained placenta (Beebe, 1995) in two provinces of South
Africa (Limpopo and North-West). Farmers were interviewed in
groups using open-ended questions at the dipping tanks or
individually thereafter. Information was also gathered from
previous work done in Madikwe Reserve, North-West Province,
South Africa (Van der Merwe et al., 2001). The veterinaryconsistency (Kansonia and Ansay, 1997) was used for empiric
validation of the information. Plants were collected under
guidance of farmers and only when the same plant was
designated by at least two individuals for the same pathology
was the information judged acceptable. Voucher specimens
were submitted to the South African National Biodiversity
Institute for identification and thereafter kept in the Herbarium
at Onderstepoort Veterinary Institute. Table 1 lists the plants
used in the treatment of wounds and retained placenta.
2.2. Plant processing and extraction
Plant materials (leaves, stems, bark or entire plant) were dried
in the shade at room temperature before grinding to fine powders
using a Buchi mixer (Labotec®). Approximately 5 g of ground
material was extracted by sonication with dichloromethane
(DCM) and 90% methanol (10 ml/g) (MeOH) respectively for
1 h. The extractants were filtered using Whatman No. 1 filter
paper. All extracts were dried under reduced pressure at 40 °C.
2.3. Antibacterial activity
Antibacterial screening was carried out using the microplate
method for minimum inhibitory concentration (MIC) determina-
tion (Eloff, 1998). Two milliliters of cultures of three bacterial
strains: Staphylococcus aureus (ATCC 29213), Escherichia coli
(ATCC 25922) and Pseudomonas aeruginosa (ATCC 27853)
Table 2
Antibacterial activity (MIC) of plant extracts (mg/ml) used in South African
ethnoveterinary medicine as determined using the micro-dilution assay
Plant species Part tested DCM extracts 90% MeOH extracts
S.a. E.c. P.a. S.a E.c. P.a.
A. marlothii Leaves 0.31⁎ 1.25 1.25 1.25 1.25 1.25
C. spicata Bark 1.25 1.25 1.25 1.25 1.25 1.25
C. quandrangularis Stem 0.63⁎ 2.5 2.5 0.31⁎ 1.25 2.5
D. eriocarpum Shoots 0.63⁎ 2.5 2.5 0.31⁎ 1.25 1.25
J. zeyheri Root 0.63⁎ 1.25 2.5 2.5 0.63⁎ 2.5
P. angolensis Bark 0.31⁎ 0.63⁎ 2.5 2.5 0.63⁎ 2.5
R. communis Leaves/Stem 0.16⁎ 0.24⁎ 1.25 1.25 0.4⁎ 0.78
S. pinnata Shoots 0.31⁎ 0.63⁎ 1.25 0.31⁎ 0.31⁎ 1.25
S. viminale Stem 1.25 1.25 1.25 1.25 1.25 1.25
Z. mucronata Bark 2.5 2.5 2.5 2.5 2.5 1.25
S.a.=Staphylococcus aureus; E.c.=Escherichia coli; P.a.=Pseudomonas aer-
uginosa. Values with astersisks (⁎) are considered as active. The MIC values
(μg/ml) for Neomycin® (positive control) were: E. coli=2.44; P. aerugi-
nosa=0.78; S. aureus=0.305.
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overnight cultures were diluted with sterile MH broth (1 ml
bacteria/50 ml MH). The DCM and MeOH extract residues were
redissolved in acetone to a final concentration of 20 mg/ml. For
each of the three bacteria used, 100 μl of each of the plant extracts
tested was two-fold serially diluted with 100 μl sterile distilled
water in a sterile 96-well micro-plate. A similar two-fold serial
dilution of neomycin (Sigma) (0.1 mg/ml) was used as a positive
control against each bacterium. One hundred microliters of each
bacterial culture was added to eachwell. The plates (two replicates
and two repeats) were covered and incubated overnight at 37 °C.
To indicate bacterial growth, 50 μl of 0.2 mg/ml p-iodonitrote-
trazolium violet (INT) (Sigma Chemical Company, St Louis, MO)
was added to each well and the plates incubated at 37 °C for
30min. Bacterial growth inhibitionwas indicated by a reduction in
the red colour whereas clear wells indicated a lethal effect.
2.4. Anti-inflammatory activity
Anti-inflammatory activity was determined using the
cyclooxygenase-1 and 2 assays as described by Zschocke and
Van Staden (2000). The COX-1 (isolated from ram seminal
vesicles) and COX-2 (human recombinant) (Sigma-Aldrich)
enzymes were activated with co-factor solution and pre-
incubated on ice for 5 min. Sixty microliters of this enzyme/
co-factor solution was added to 20 μl of test solution (2.5 μl of
the compound ethanolic solutions+17.5 μl water) and pre-
incubated for 5 min at room temperature. Twenty microliters of
[1-14C]arachidonic acid was added to the tested samples and
incubated at 37 °C for 10 min. After incubation, the reaction
was terminated by adding 10 μl 2 N HCl. Four controls were
run. Two were background in which the enzyme was inactivated
with HCl before the addition of [1-14C]arachidonic acid, and
two were solvent blanks. Indomethacin was included as a
standard. Percentage inhibition of the tested compound was
calculated by comparing the amount of radioactivity present in
the sample to that in the blank solvent.
2.5. Mutagenicity test
Mutagenicity was tested using the Salmonella microsome
assay based on the plate-incorporation procedure with Salmo-
nella typhimurium tester strain TA98. The assay was performed
according to Maron and Ames (1983). Stock (100 μl) bacteria in
20 ml Oxoid nutrient broth No. 2 were incubated for 16 h at
37 °C. The bacterial cultures (100 μl) were added to 100 μl of
plant extract in 500 μl phosphate buffer and 2 ml of agar
containing biotin–histidine (0.5 mM). The mixture was poured
on a minimal agar plate and incubated at 37 °C for 48 h. Samples
were tested in triplicate with two replicates. Three dilutions (50,
500, 5000 μg) were used per sample. 4-Nitoquinoline-N-oxide
(4NQO) was used as a positive control.
3. Results and discussion
Wounds of several months duration with deep structure
alterations are most frequently polymicrobial, involving numerousmicroorganisms that are potentially pathogenic (Bowler et al.,
2001). This might be the case in EVM because farmers, most
frequently, treat old wounds. The results of the general screening
for antibacterial activity (MIC values) as shown in Table 2 suggest
that five plants are effective in treatment of wounds because they
are effective against at least S. aureus and E. coli. S. aureus and
coagulase-negative staphylococci are the predominant organisms
isolated from different types of wounds (Howell-Jones et al.,
2005). The most effective plants were Cissus quandrangularis,
J. zeyheri, P. angolensis, R. communis and S. pinnata. Of the 20
plant extracts screened, nine (6 DCM and 3 MeOH) showed
activity against S. aureus while seven inhibited E. coli growth.
None of the plant extracts was effective againstP. aeruginosa. The
results for anti-inflammatory activity of the different plant extracts
are given in Table 3. DCM extracts of C. quandrangularis,
P. angolensis and S. pinnata showed high inhibitory activity
against COX-1 (N60%). On the other hand, extracts of
C. quandrangularis (DCM and 90% MeOH), MeOH extracts of
D. eriocarpum, DCM extracts of J. zeyheri and P. angolensis
showed high inhibitory activity against COX-2 (N70%). COX-1 is
the constitutive form which has a clear physiological function
whereas COX-2 is induced by mediatory inflammation (Botting,
2006). However, it is worthmentioning that prolonged use of plant
extracts that showed selectivity to either COX enzymes may have
detrimental effects. Prolonged use of COX-1 selective inhibitors
causes severe damage to the gastrointestinal tract (Méric et al.,
2006), while COX-2 selective inhibitors which cause less or no
gastrointestinal damage result in cardiovascular adverse effects
(Modica et al., 2005).
The validation of the use of plants in traditional medicine based
on the results with organic solvents might be considered irrelevant
because traditionally, water instead is used as a solvent for most of
the preparations (Elgorashi andVan Staden, 2004). However, in the
case of wound treatment in livestock, this dilution factor could be
considered insignificant because the whole plant material is
processed and applied as such locally giving the opportunity for
the substances to be released. It is also not known what changes
occur when themixtures, given orally, are digested by the animal in
Table 3
Inhibition (%) of prostaglandin synthesis by extracts (250 μg/ml) obtained from plants used in South African ethnoveterinary medicine as determined by the
cyclooxygenase (COX-1 and -2) assays
Plant species Part used COX-1 COX-2
DCM Methanol DCM Methanol
A. marlothii Leaves 42.3±2.5 21.8±0.9 8.3±2.5 0
C. spicata Root 35.2±5.3 28.4±5.7 2.1±1.2 19.2±4.3
C. quandrangulata Stem 62.3±1.5 23±5.8 75.8±4.1⁎ 70.3±3.9⁎
D. eriocarpum Shoots 35.5±0.4 33.5±5.5 16.7±2.5 77±3.2⁎
J. zeyheri Root 43.0±5.3 17.3±0.8 77±2.8⁎ 25±1.4
P. angolensis Bark 87.5±2.3⁎ 59.3±0.6 83±1.4⁎ 19.5±2.1
R. communis Leaves/Stem 36.1±5.9 36.2±1.7 14.7±0.7 9.1±2.4
S. pinnata Shoots 93.4±4.5⁎ 9.8±2.8 54.7±2.5⁎ 0
S. viminale Stem 44.7±5.7 31.3±4.2 18.7±1.1 25.5±5.6
Z. mucronata Bark 43.1±0.8 68.5±7.8 44.5±4.1 66.2±4.6⁎
Values with asterisks (⁎) are considered as active. The percentage prostaglandin synthesis inhibition by indomethacin® (positive control) in COX-1 was 71.8–79.8%
and in COX-2 54–70%.
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ingredients are then released and the materials become effective.
Some plants have obvious properties that are expected to stimulate
healing or combat infections. For instance,C. quandrangularis has
a high content of vitamin C, carotene A, calcium and anabolic
steroidal substances (Deka et al., 1994; Demling, 2000). J. zeyheri
is one of the most used and stored plants by the Tsonga speaking
people (Luseba andVanderMerwe, 2006). It contains a diterpenoid
that showed antibacterial activity against Streptococcus pyogenes
and some fungi (Dekker et al., 1987). P. angolensis compares well
with J. zeyheri in Tsonga Traditional Medicine with regard to
frequency of use.P. angolensis is well known for its tannin content.
This may explain its antibacterial activity. S. pinnatawas shown to
exhibit good antibacterial activity on many other bacteria including
Cornebacterium, Diphthericeae, Neisseria, Streptococcus and
Streptobacillus spp. (Hussein and Deeni, 1991). R. communis
proved to be the most potent plant with the best MIC values.
Leaves, roots and seed oil of this plant have been studied
extensively and compounds isolated comprise tannins, flavonoids
and indole-3-acetic acid. Flavonoids are reported to have anti-
inflammatory activity (Ilavarasan et al., 2006). This explains why
Duke (1983) reported its indication in more than 80 ailments ofTable 4
Number of His+ revertants in Salmonella typhimurium strain TA98 produced by cru
Plant species Plant part Number of colonies
DCM extracts (μg/ml)
5000 500
A. marlothii Leaves 24±2.1 23.6±3.1
C. spicata Root 31.3±3.2 32±5.3
C. quandrangulata Stem 23.3±7.3 27.0±4.3
D. eriocarpum Whole plant 48±3 29.3±5.7
P. mixta Stem 38.3±6.6 31.3±2.3
J. zeyheri Root 24±1.7 25.6±1.2
P. angolensis Bark 20±7.8 25.3±3.2
R. communis Leaves/Stem 33±7 38.6±3.7
S. pinnata Aerial parts 38.5±7.7 33±4.3
S. birrea Bark 27.5±3.5 31.6±7.7
S. viminale Stem 30.3±0.7 30.3±1.4
Z. mucronata Bark 27.5±2.1 37.6±2.8which the majority are of an inflammatory nature. Water extracts
were not evaluated because from our experience, their antibacterial
activities aremost of the time not detectable. For instance, 23 out 27
water plant extracts were not active for plant used for medicinal
purposes (infections) (Rabe and Van Staden, 1997).
The concept of inflammation might not be distinct from that
of infection among local farmers. It was shown that farmers do
not use different plants for different degrees of inflammation or
stages of infection (Van der Merwe et al., 2001). Surprisingly, in
this study, the same plants showed simultaneously good
antibacterial and anti-inflammatory activities. As is the case
for antibacterial activity, the anti-inflammatory activity of some
plant extracts can be explained by the chemical constituents of
the plant. For instance, for S. pinnata, this can be attributed to
procyanidin. Procyanidin has an antioxidant effect and has been
used in inflammatory diseases and wound healing (Grim et al.,
2004). The peroxynitrite scavenging properties of procyanidins
condense tannin oligomers and can protect endothelial cells
from damage (Stoclet et al., 2004). The anabolic steroids found
in C. quandrangularis might also improve the healing process
indirectly. They are thought to counteract the catabolic effects of
some substances on wound healing (Ovington, 1998). Thede plant extracts
90% Methanol extracts (μg/ml)
50 5000 500 50
32.3±6.1 29.6±1.2 36.3±3.7 37±1.7
31.3±6.4 36.3±4.9 37±3.6 23±1.4
24.0±7.0 30.6±2.5 28.3±4.5 36.3±3.5
35±5.3 36.3±6.4 26.6±2.8 27.6±4.7
33±1.4 30.3±3.2 29±6.9 27±3
28.6±2.1 25±3 28±5 26.6±2.1
27.3±4.5 22.3±2.5 25.6±4.0 24±3.6
35±2 35.6±6.8 36.1±1.4 38.3±2.1
32±5.3 32±1 32±3 30±5
30.0±2.1 34.6±7.5 33.6±2.8 32±2.1
32±3.6 34.6±6.4 28±6 28.3±2.3
33.6±2.3 32.3±4.9 37.6±1.2 37.6±6
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were reported to have very high and significant anti-
inflammatory activity (Osadebe and Okoye, 2003) suggesting
that plants such as P. angolensis and J. zeyheri have the same
effect due to their tannin content and flavanoids.
Chronic and non-healing wounds are frequently hypoxic as a
consequence of poor blood perfusion (Bowler et al., 2001). In
general wound management, it is usually recommended to sur-
gically remove all foreign bodies and aerate the site. We suspect
that by using irritating plants as EVM remedies, this function is
achieved and the positive results obtained in this study support this
assertion.
With reference to retained placenta in particular, it is common
knowledge in veterinarymedicine that the placental membranes are
normally released between 2 and 6 h post-partum. Retained
placenta is defined as retention of foetal membranes for longer than
12 h post-partum. However, in untreated animals, retained placenta
would be released between 2 and 10 days (Eilen and Hopkins,
1993). Farmers have reportedly used medicinal plants during this
period. In this case, it is difficult to conclude that plants are used for
their known biological properties. However, it was noted that some
plants used in the treatment of retained placenta have both mechan-
ical and biological properties. Previous research (Van der Merwe
et al., 2001) attributes this to the Doctrine of Signatures. The
Doctrine of Signatures is a metaphysical method of discovering
pharmaceutical value. It proposes the idea thatGod gave everything
in nature its unique healing powers that can be discovered in its
appearance. The soapy aspect of D. eriocarpum may have a
soothing and cooling effect on inflamed skin andmucosa lesions as
noted for A. marlothii by Van Wyk et al. (1997). The scientific
validation could also be based on plant constituents. Tannin-
containing plants such asP. angolensis and S. pinnata are probably
effective where protection of underlying tissues by skin or mucosa
is compromised as seen in the case of wounds and retained
placenta. Tannin–protein complexation limits fluid loss and forms a
physical barrier to further tissue insult. They have also a
vasoconstructive effect on small blood vessels that limits bleeding
and oozing of fluids through damaged skin or mucous membranes
(Bruneton, 1995). We can also speculate that the well-known
astringent property of tannins has a physiological effect such as a
contraction of the uterus which might facilitate the removal of
retained placenta. According to Manspeaker (2007), by shrinking
of the small blood vessels, the capillary pressure is lessened and
separation of foetal membranes occurs.
The Ames test which was used in this study to detect genetic
damage induced directly or indirectly usingS. typhimurium (TA98)
is based on the number of His+ revertants in S. typhimurium strain
TA98 produced by crude plant extracts. An extract was considered
mutagenic if the number of revertants per plate (mean of 5 or 3
replicate plates as indicated above) was at least double that of the
spontaneous revertant frequency. None of the plant extracts had a
value approaching the value indicating genotoxicity. It should be
noted, however, leaf extracts of Ziziphus mucronata showed
genotoxic effects in human peripheral blood lymphocytes using
the micronucleus and the alkaline comet assays for both the DCM
and MeOH extracts. Furthermore, MeOH extracts from the roots
of R. communis were genotoxic in the micronucleus test (Tayloret al., 2003). These plants are perhapsmore dangerous considering
that they are used for extended periods of time and may cause
long-term damage to the animals. Although the results were
negative, the mutagenicity data are reported in Table 4 for refer-
ence purpose.
4. Conclusion
As far as we can ascertain, this work is the first to report on
the antibacterial and anti-inflammatory activities of ethnoveter-
inary remedies used in the treatment of wounds and retained
placenta. The results indicate that most plants used traditionally
for treating these pathologies might be effective although
organic solvents were used rather than the water decoctions or
infusions used by farmers. Furthermore, lack of mutagenicity
suggests that most of these plants are probably safe though other
tests need to be conducted for further safety testing.
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